K Number
K980046
Device Name
BRONCHIAL CATHETER SYSTEM
Date Cleared
1998-05-01

(115 days)

Product Code
Regulation Number
874.4680
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Bronchial Catheter System is intended to be used for foreign body removal and bronchial hemostasis.
Device Description
Not Found
More Information

Not Found

Not Found

No
The summary does not mention AI, ML, image processing, or any other technology typically associated with AI/ML in medical devices. The performance studies focus on equivalence to predicate devices, which are standard medical devices without AI/ML.

Yes
The device is used for removal of foreign bodies and bronchial hemostasis, which are therapeutic interventions.

No
The stated intended use is for foreign body removal and bronchial hemostasis, which are therapeutic interventions, not diagnostic ones.

No

The device is described as a "Bronchial Catheter System" and its performance evaluation is for a "Bronchial Balloon Catheter," indicating a physical device. The predicate devices are also physical catheters and an electrosurgical generator. There is no mention of software as the primary component or function.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is "for foreign body removal and bronchial hemostasis." This describes a therapeutic or interventional procedure performed directly on a patient's body, not a test performed on a sample taken from the body to diagnose a condition.
  • Anatomical Site: The anatomical site is "Bronchial," which is a part of the respiratory system within the body.
  • Lack of IVD Characteristics: There is no mention of analyzing samples (like blood, urine, tissue, etc.), diagnostic testing, or providing information for diagnosis.

IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device's function is clearly procedural and therapeutic.

N/A

Intended Use / Indications for Use

The Bronchial Catheter System is intended to be used for foreign body removal and bronchial hemostasis.

Product codes

77 EOO, 79 GEI

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Bronchial

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

The performance of the Bronchial Balloon Catheter was evaluated in vitro and shown to be equivalent to the performance of the predicate devices.

Key Metrics

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 874.4680 Bronchoscope (flexible or rigid) and accessories.

(a)
Identification. A bronchoscope (flexible or rigid) and accessories is a tubular endoscopic device with any of a group of accessory devices which attach to the bronchoscope and is intended to examine or treat the larynx and tracheobronchial tree. It is typically used with a fiberoptic light source and carrier to provide illumination. The device is made of materials such as stainless steel or flexible plastic. This generic type of device includes the rigid ventilating bronchoscope, rigid nonventilating bronchoscope, nonrigid bronchoscope, laryngeal-bronchial telescope, flexible foreign body claw, bronchoscope tubing, flexible biopsy forceps, rigid biopsy curette, flexible biopsy brush, rigid biopsy forceps, flexible biopsy curette, and rigid bronchoscope aspirating tube, but excludes the fiberoptic light source and carrier.(b)
Classification. Class II.

0

Bronchial Catheter System

510(k) Summary of Safety and Effectiveness 10000 ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------MAY

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

The assigned 510(k) number is: K180046

Applicant Information:

Date Prepared:January 5, 1998
Name:Broncus Technologies, Inc.
Address:1400N. Shoreline Boulevard
Mountain View, CA 94043
Contact Person:Glendon E. French
Phone Number:(650) 428-1600
Fax Number:(650) 428-1542

Device Information:

ClassificationClass II
Trade Name:Bronchial Catheter System
Classification Name:Bronchoscope and Accessories
21 CFR 874.4680

Equivalent Devices:

The subject device is substantially equivalent in intended use and/or method of operation to a combination of the following predicate devices:

  • Disposable Balloon Catheters 1. Olympus
  • Microvasive Gold Probe Direct Boston Scientific 2.
    1. Valleylab, Inc. Force 2 Electrosurgical Generator

Intended Use:

The Bronchial Catheter System is intended to be used for foreign body removal and bronchial hemostasis.

1

510(k) Summary of Safety and Effectiveness, continued

Comparison To Predicate Devices:

The Broncus Technologies Bronchial Catheter System is equivalent in intended use and operational characteristics to the Olympus Disposable Balloon Catheters and the Microvasive Gold Probe when used with the Valleylab Force 2 RF Generator.

Non-Clinical Test Results:

Performance

The performance of the Bronchial Balloon Catheter was evaluated in vitro and shown to be equivalent to the performance of the predicate devices.

Biocompatibility

The materials used in the Bronchial Balloon Catheter have proven biocompatibility.

Summary:

Based on the intended use, product, performance and biocompatibility information provided in this notification, the subject device has been shown to be substantially equivalent to currently marketed predicate devices.

2

Image /page/2/Picture/0 description: The image shows the text "DEPARTMENT OF HEALTH & HUMAN SERVICES" in all caps. The text is in a bold, serif font. The words are arranged on a single line and centered.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAY 1 1998

Bronchus Technologies, Inc.

Mountain View, California 94043

1400 N. Shoreline Blvd. Building A. Suite 8

Glendon E. French

President and CEO

Re:

K980046 Bronchial Catheter System Dated: April 10, 1998 Received: April 13, 1998 Regulatory class: II 21 CFR 874.4680/Procode: 77 EOO 21 CFR 878.4400/Procode: 79 GEI

Dear Mr. French:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (2) CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmaldsmamain.html".

Sincerely yours,

Kilian Yin, Ph.D.

Lillian Yin, Ph.D. Director, Division of Reproductive Abdominal, Ear, Nose and Throat and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

Indications for Use

K980046 510(k) Number (if known):

Device Name:

Bronchial Catheter System

Indications for Use:

The Bronchial Catheter System is intended for foreign body removal and bronchial hemostasis.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devj 510(k) Number Prescription Use OR Over- The Counter Use _______ (Per 21 CFR 801.109) -

(Optional Format 1-2-96)